Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

5.95p
   
  • Change Today:
      0.050p
  • 52 Week High: 20.04
  • 52 Week Low: 5.59
  • Currency: UK Pounds
  • Shares Issued: 585.67m
  • Volume: 1,498,708
  • Market Cap: 34.85m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-22 Interim 2.03 (11.43) (4.86)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 0.64 (20.99) (16.05)p n/a n/a n/a n/a 0.0%
31-Dec-18 11.88 (5.15) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.72 (9.07) (7.55)p n/a n/a n/a n/a 0.0%
31-Dec-20 10.39 (1.89) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.52 (19.57) (8.74)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 7.94 (19.27) (8.32)p n/a n/a n/a n/a 0.0%
31-Dec-23 26.60 (23.37) (4.59)p n/a n/a n/a n/a 0.0%
31-Dec-24 84.01 6.33 0.03p 178.5 n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

STX Market Data

Currency UK Pounds
Share Price 5.95p
Change Today 0.050p
% Change 0.85 %
52 Week High 20.04
52 Week Low 5.59
Volume 1,498,708
Shares Issued 585.67m
Market Cap 34.85m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.31% above the market average15.31% above the market average15.31% above the market average15.31% above the market average15.31% above the market average
70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average
Price Trend
90.39% below the market average90.39% below the market average90.39% below the market average90.39% below the market average90.39% below the market average
61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average
Income Not Available
Growth
19.87% above the market average19.87% above the market average19.87% above the market average19.87% above the market average19.87% above the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 24-Mar-2023

Time Volume / Share Price
16:50 450,000 @ 5.97p
16:47 450,000 @ 5.97p
16:35 15 @ 6.00p
16:08 100,302 @ 5.97p
15:50 67,000 @ 6.00p

Top of Page